Overexpression of MACC1 protein and its clinical implications in patients with glioma

Tumor Biology

Volumn 35, Issue 1, 2014, Pages 815-819

  Yang, Tao ^a,b   Kong, Bin ^a,b   Kuang, Yong Qin ^a   Cheng, Lin ^a   Gu, Jian Wen ^a   Zhang, Jun Hai ^a   Shu, Hai Feng ^a   Yu, Si Xun ^a   He, Wei Qi ^a   Xing, Xue Min ^a   Huang, Hai Dong ^a  

^a CHENGDU MILITARY GENERAL HOSPITAL   (China)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Biomarker; Glioma; MACC1; Prognosis

Indexed keywords

BIOLOGICAL MARKER; MESSENGER RNA; METASTASIS ASSOCIATED IN COLON CANCER 1 PROTEIN; TUMOR PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BRAIN TISSUE; CANCER GRADING; CANCER PROGNOSIS; CANCER SURVIVAL; CANCER TISSUE; CARCINOGENESIS; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; GENE OVEREXPRESSION; GLIOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION;

ADULT; AGED; BRAIN NEOPLASMS; FEMALE; GENE EXPRESSION; GLIOMA; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM GRADING; REAL-TIME POLYMERASE CHAIN REACTION; TRANSCRIPTION FACTORS; TUMOR BURDEN;

EID: 84894501690     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-013-1112-5     Document Type: Article

References (17)

1. Liu X, Tang H, Wang Z, Huang C, Zhang Z, She X, et al. F10 gene hypomethylation, a putative biomarker for glioma prognosis. J Neurooncol. 2012;107:479-85. doi:10.1007/s11060-011-0775-2.
2. Rousseau A, Mokhtari K,Duyckaerts C. The 2007WHOclassification of tumors of the central nervous system-what has changed? Curr Opin Neurol. 2008;21:720-7. doi:10.1097/WCO.0b013e328312c3a7.
3. Brandes AA. State-of-the-art treatment of high-grade brain tumors. Semin Oncol. 2003;30:4-9.
4. Ohgaki H, Kleihues P. Epidemiology and etiology of gliomas. Acta Neuropathol. 2005;109:93-108.
5. Hutterer M, Knyazev P, Abate A, ReschkeM,Maier H, Stefanova N, et al. Axl and growth arrest-specific gene 6 are frequently overexpressed in human gliomas and predict poor prognosis in patients with glioblastoma multiforme. Clin Cancer Res. 2008;14: 130-8. doi:10.1158/1078-0432.CCR-07-0862.
6. Tabatabai G, Hegi M, Stupp R, Weller M. Clinical implications of molecular neuropathology and biomarkers for malignant glioma. Curr Neurol Neurosci Rep. 2012;12:302-7. doi:10.1007/s11910-012-0263-x.
7. Stein U, Walther W, Arlt F, Schwabe H, Smith J, Fichtner I, et al. MACC1, a newly identified key regulator of HGF-MET signaling, predicts colon cancer metastasis. Nat Med. 2009;15:59-67. doi:10.1038/nm.1889.
8. Arlt F, Stein U. Colon cancer metastasis: MACC1 and Met as metastatic pacemakers. Int J Biochem Cell Biol. 2009;41:2356-9. doi:10.1016/j.biocel.2009. 08.001.
9. Isella C, Mellano A, Galimi F, Petti C, Capussotti L, De Simone M, et al.MACC1 mRNA levels predict cancer recurrence after resection of colorectal cancer liver metastases. Ann Surg. 2013;257:1089-95. doi:10.1097/SLA. 0b013e31828f96bc.
10. Shirahata A, SakataM, Kitamura Y, Sakuraba K, Yokomizo K, Goto T, et al. MACC 1 as a marker for peritoneal-disseminated gastric carcinoma. Anticancer Res. 2010;30:3441-4.
11. Chundong G, Uramoto H, Onitsuka T, Shimokawa H, Iwanami T, Nakagawa M, et al. Molecular diagnosis of MACC1 status in lung adenocarcinoma by immunohistochemical analysis. Anticancer Res. 2011;31:1141-5.
12. Shimokawa H, Uramoto H, Onitsuka T, Chundong G, Hanagiri T, Oyama T, et al. Overexpression of MACC1 mRNA in lung adenocarcinoma is associated with postoperative recurrence. J Thorac Cardiovasc Surg. 2011;141:895-8. doi:10.1016/j.jtcvs.2010.09.044.
13. Shirahata A, Fan W, Sakuraba K, Yokomizo K, Goto T, Mizukami H, et al. MACC 1 as a marker for vascular invasive hepatocellular carcinoma. Anticancer Res. 2011;31:777-80.
14. Xie C,Wu J, Yun J, Lai J, Yuan Y, Gao Z, et al. MACC1 as a prognostic biomarker for early-stage and AFP-normal hepatocellular carcinoma. PLoS One. 2013;8:e64235. doi:10.1371/journal.pone.0064235.
15. Huang Y, Zhang H, Cai J, Fang L,Wu J, Ye C, et al. Overexpression of MACC1 and its significance in human breast cancer progression. Cell Biosci. 2013;3:16. doi:10.1186/2045-3701-3-16.
16. Yang YP, Qu JH, Chang XJ, Lu YY, Bai WL, Dong Z, et al. High intratumoral metastasis-associated in colon cancer-1 expression predicts poor outcomes of cryoablation therapy for advanced hepatocellular carcinoma. J Transl Med. 2013;11:41. doi:10.1186/1479-5876-11-41.
17. Stein U, Dahlmann M, Walther W. MACC1-more than metastasis? Facts and predictions about a novel gene. J MolMed (Berl). 2010;88: 11-8. doi:10.1007/s00109-009-0537-1.